Evidence map›Paper›PMID 26976859›Full record

ArticleAntimicrobial agents and chemotherapy2016

VIM-47, a New Variant of the Autochthonous Metallo-β-Lactamase VIM-13 from the Balearic Islands in Spain.

Laura Zamorano, Xavier Mulet, Margarita Garau, Carmen Gallegos, Carlos Juan, José L Pérez, Antonio Oliver

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura ZamoranoServicio de Microbiología and Unidad de Investigación, Hospital Son Espases, Palma de Mallorca, Spain Instituto de Investigación Sanitaria de Palma (IdISPa), Palma de Mallorca, Spain laura.zamorano@ssib.es.
Xavier MuletServicio de Microbiología and Unidad de Investigación, Hospital Son Espases, Palma de Mallorca, Spain Instituto de Investigación Sanitaria de Palma (IdISPa), Palma de Mallorca, Spain.
Margarita GarauInstituto de Investigación Sanitaria de Palma (IdISPa), Palma de Mallorca, Spain Servicio de Microbiología, Hospital Son Llàtzer, Palma de Mallorca, Spain.
Carmen GallegosInstituto de Investigación Sanitaria de Palma (IdISPa), Palma de Mallorca, Spain Servicio de Microbiología, Hospital Son Llàtzer, Palma de Mallorca, Spain.
Carlos JuanServicio de Microbiología and Unidad de Investigación, Hospital Son Espases, Palma de Mallorca, Spain Instituto de Investigación Sanitaria de Palma (IdISPa), Palma de Mallorca, Spain.
José L PérezServicio de Microbiología and Unidad de Investigación, Hospital Son Espases, Palma de Mallorca, Spain Instituto de Investigación Sanitaria de Palma (IdISPa), Palma de Mallorca, Spain.
Antonio OliverServicio de Microbiología and Unidad de Investigación, Hospital Son Espases, Palma de Mallorca, Spain Instituto de Investigación Sanitaria de Palma (IdISPa), Palma de Mallorca, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial Agentsbeta-LactamasesHumansIntegronsIslandsMicrobial Sensitivity TestsPseudomonas aeruginosaPseudomonas InfectionsSpainAnti-Bacterial Agentsbeta-Lactamasesmetallo-beta-lactamase (VIM-13), Pseudomonas aeruginosa

Identifiers

PMID26976859
PMCPMC4862452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.